View Agenda and Presentations

This short course was intended to inform participants about systematic approaches for evidence-based assessment of genetic tests.  The content was developed to be useful to public health and health care professionals, policy makers, and others who are involved in the development, evaluation, utilization, regulation, and reimbursement of genetic tests for screening and prevention.  Speakers addressed issues related to pre- and post-market evaluation of genetic tests, and included case studies and lessons learned from the CDC-sponsored ACCE Project and other review processes.The more than 60 professionals from the United States, Canada, the United Kingdom and the Netherlands who attended the short course were from state and Federal public health agencies, health care practice, health care provider organizations, industry, voluntary health organizations and advocacy groups, academic centers, and health technology assessment centers.

Centers for Disease Control & Prevention

Foundation for Blood Research

Muin Khoury, MD, PhD Director, OGDP, CDC Linda A. Bradley, PhD Geneticist, OGDP, CDC Melanie F. Myers, PhD Public Health Geneticist, OGDP, CDC Paula W. Yoon, ScD, MPH Epidemiologist, OGDP, CDC D. Joe Boone, PhD Associate Director for Science, Public Health Practice Program Office, CDC Peter A. Briss, MD, MPH Chief, Community Guide Branch, CDC Scott Grosse, PhD Health Economist, National Center for Birth Defects and Developmental Disabilities, CDC

James E. Haddow, MD Medical Director, FBR Glenn E. Palomaki, BS Director, Biometry/Epidemiology, FBR Monica McClain, PhD Asst. Director, Biometry/Epidemiology, FBR